The largest listing on the London Stock Exchange is set to go ahead next week as GlaxoSmithKline investors voted to demerge its newly-created consumer healthcare unit Haleon. The vote to demerge passed overwhelmingly on Wednesday (13 July), with 99.8% voting in favour of the break-up. Next Monday (1...

Join International Investment to continue reading

Read the full article by logging in or joining to gain access to our premium content and members-only insights.

Subscribe Login